The present study aimed to investigate the effect of the pioglitazone PPAR-γ agonist on the mTOR pathway in pentylenetetrazol (PTZ)-induced status epilepticus (SE), and examine the expression levels of the IL-1β and IL-6 inflammatory factors. The gene discussed is PPARG; the disease is status epilepticus.